Translational neuroprotection research in glaucoma: A review of definitions and principles

Clinical and Experimental Ophthalmology

Volumn 40, Issue 4, 2012, Pages 350-357

  Casson, Robert J ^a   Chidlow, Glyn ^a   Ebneter, Andreas ^a   Wood, John Pm ^a   Crowston, Jonathan ^b   Goldberg, Ivan ^c  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Glaucoma; Glaucoma medical therapy; Glaucoma medication

Indexed keywords

BRIMONIDINE; NIMODIPINE;

CLINICAL PRACTICE; DISEASE COURSE; GLAUCOMA; HUMAN; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; QUALITY OF LIFE; RETINA NERVE CELL; REVIEW;

ANIMALS; ANTIHYPERTENSIVE AGENTS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; TERMINOLOGY AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84862577859     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02563.x     Document Type: Review

References (33)

1. Henderson AR, Temple Fay MD. Unconformable crusader and harbinger of human refrigeration, 1895-1963. J Neurosurg 1963; 20: 627-34.
2. Gill R, Foster AC, Woodruff GN. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 1987; 7: 3343-9.
3. McDonald JW, Roeser NF, Silverstein FS, Johnston MV. Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol 1989; 106: 289-96.
4. Cooper JM, Schapira AH. Mitochondrial dysfunction in neurodegeneration. J Bioenerg Biomembr 1997; 29: 175-83.
5. Lange KW, Youdim MB, Riederer P. Neurotoxicity and neuroprotection in Parkinson's disease. J Neural Transm Suppl 1992; 38: 27-44.
6. Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol 1994; 112: 37-44.
7. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study. Am J Glaucoma 2011; 151 (4): 671-81.
8. Wheeler LA, Gil DW, WoldeMussie E. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 2001; 45 (Suppl. 3): S290-4; discussion S295-6.
9. Grocott HP, Yoshitani K. Neuroprotection during cardiac surgery. J Anesth 2007; 21: 367-77.
10. Gupta N, Ang LC, Noël de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006; 90: 674-8.
11. Nork TM, Ver Hoeve JN, Poulsen GL etal. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol 2000; 118: 235-45.
12. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci 1980; 19: 126-36.
13. Quigley HA, Guy J, Anderson DR. Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch Ophthalmol 1979; 97: 525-31.
14. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci USA 2010; 107: 5196-201.
15. Howell GR, Libby RT, Jakobs TC etal. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 2007; 179: 1523-37.
16. Raff MC, Whitmore AV, Finn JT. Axonal self-destruction and neurodegeneration. Science 2002; 296: 868-71.
17. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res 2005; 24: 639-62.
18. Gilley J, Coleman MP. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 2010; 8: e1000300.
19. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23: 91-147.
20. Gupta N, Greenberg G, de Tilly LN, Gray B, Polemidiotis M, Yücel YH. Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol 2009; 93: 56-60.
21. Lagreze WA, Gaggl M, Weigel M etal. Retrobulbar optic nerve diameter measured by high-speed magnetic resonance imaging as a biomarker for axonal loss in glaucomatous optic atrophy. Invest Ophthalmol Vis Sci 2009; 50: 4223-8.
22. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-79.
23. Weber AJ, Harman CD. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest Ophthalmol Vis Sci 2005; 46: 3197-207.
24. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci 1998; 39: 2304-20.
25. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology 1995; 102: 1236-41.
26. Evans DW, Hosking SL, Gherghel D, Bartlett JD. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection. Br J Ophthalmol 2003; 87: 1463-5.
27. Gandolfi SA, Cimino L, Sangermani C, Ungaro N, Mora P, Tardini MG. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma. Invest Ophthalmol Vis Sci 2005; 46: 197-201.
28. Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003; 12: 139-50.
29. Arden G. Measuring contrast sensitivity with gratings: a new simple technique for the early diagnosis of retinal and neurological disease. J Am Optom Assoc 1979; 50: 35-9.
30. Arden GB, Jacobson JJ. A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma. Invest Ophthalmol Vis Sci 1978; 17: 23-32.
31. Atkin A, Bodis-Wollner I, Wolkstein M, Moss A, Podos SM. Abnormalities of central contrast sensitivity in glaucoma. Am J Ophthalmol 1979; 88: 205-11.
32. Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res 2005; 24: 333-54.
33. Drance SM. What can we learn from the disc appearance about the risk factors in glaucoma? Can J Ophthalmol 2008; 43: 322-7.